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DOI 10.1016/j.str.2011.06.010SUMMARY ubiquitination) versus multiple lysine residues (multimonoubiqui-The complexity of protein ubiquitination signals
derives largely from the variety of polyubiquitin
linkage types that can modify a target protein, each
imparting distinct functional consequences. Free
ubiquitin chains of uniform linkages and length are
important tools in understanding how ubiquitin-
binding proteins specifically recognize these differ-
ent polyubiquitin modifications. While some free
ubiquitin chain species are commercially available,
mutational analyses and labeling schemes are
limited to select, marketed stocks. Furthermore, the
multimilligram quantities of material required for
detailed biophysical and/or structural studies often
makes these reagents cost prohibitive. To address
these limitations, we have optimized knownmethods
for the synthesis and purification of linear, K11-, K48-,
and K63-linked ubiquitin dimers, trimers, and tetra-
mers on a preparative scale. The high purity and rela-
tively high yield of these proteins readily enables
material-intensive experiments and provides flexi-
bility for engineering specialized ubiquitin chain
reagents, such as fluorescently labeled chains of
discrete lengths.
INTRODUCTION
Protein ubiquitination serves as a critical regulatory mechanism
for a wide array of cellular processes (Pickart and Fushman,
2004). Posttranslational modification of a target protein by the
small, 76 amino acid ubiquitin molecule occurs through a
multistep enzymatic cascade that includes an ATP-dependent
E1 ubiquitin-activating enzyme, an E2 ubiquitin-conjugating
enzyme and an E3 ubiquitin ligase, culminating in the attachment
of the ubiquitin C terminus to the ε-amino group of a primary
amine, generally a lysine residue. While some E3 ligases, such
as the HECT family, directly couple ubiquitin to the substrate,
others act to pair protein targets with E2 enzymes that catalyze
the ubiquitin attachment. In either case, an E3 ligase drives
substrate selection, with ubiquitination of a single lysine (mono-Structure 19, 1053–tination) potentially leading to differential cellular fates for a single
protein target (Harper and Schulman, 2006; Kirkpatrick et al.,
2006).
Further signal complexity arises from the extension of ubiquitin
polymers on substrate proteins, which can assemble via any one
of the seven ubiquitin lysine residues, or N terminus. Although
the functional consequences of each polyubiquitin chain type
are still being elucidated, clear cellular outcomes have been
observed for the most abundant chain linkages. For example,
ubiquitin chains conjugated through lysine 48 (K48-linked) are
well characterized to promote proteasomal degradation of the
modified protein (Chau et al., 1989; Ikeda and Dikic, 2008).
K11-linked ubiquitin tags have also been shown to act as degra-
dation signals for substrates of the anaphase promoting
complex (APC) in cell division regulation, whereas K63-linked
polyubiquitin chains have been best studied in their nonproteo-
lytic roles in proinflammatory signaling and DNA repair pathways
(Baboshina and Haas, 1996; Chen and Sun, 2009; Jin et al.,
2008; Kirkpatrick et al., 2006). The biology of other linkages,
such as linear ubiquitin, is becoming better defined with
continued research (Gerlach et al., 2011; Ikeda et al., 2011; Ikeda
and Dikic, 2008; Iwai and Tokunaga, 2009; Jin et al., 2008; Toku-
naga et al., 2011; Virdee et al., 2010; Xu et al., 2009).
Indeed, current research in the field aims to elucidate the
molecular mechanisms by which these diverse polyubiquitin
signals are assembled and interpreted by cellular receptors.
These efforts were greatly aided by the discovery that select
E2 enzymes are capable of catalyzing the formation of polyubi-
quitin chains of specific linkages in vitro, without the presence
of an E3 ligase (Chen and Pickart, 1990; Chen et al., 1991; Wu
et al., 2010). In addition to identifying simplified systems with
which to probe the mechanism of ubiquitin chain formation,
these findings also provided a means of preparing free (i.e., un-
coupled to substrate) polyubiquitin chains that can be used to
evaluate how ubiquitin-binding proteins distinguish between
distinct polyubiquitin signals.
Initial chain synthesis protocols for K48- or K63-linked chains
of defined length were particularly focused on the preparation of
ubiquitin dimers (or longer constructs) that had distinguishable
distal and proximal protomers for NMR studies and relied on
successive rounds of conjugation and deblocking steps, using
mixed populations of lysine-blocked and C-terminally blocked
mutants, to force protomer orientation (Piotrowski et al., 1997;1063, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1053
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Preparation of Linkage-Specific Ubiquitin ChainsPickart and Raasi, 2005; Varadan et al., 2002a). While these
methods remain useful for differentially labeling ubiquitin proto-
mers within a chain or for making defined linkage chains (Blan-
kenship et al., 2009; Newton et al., 2008; Reyes-Turcu et al.,
2008; Varadan et al., 2004, 2005), one can also use wild-type
ubiquitin stocks and specific E2 enzymes to produce milligram
quantities of ubiquitin homopolymers of discrete lengths in
a one-step synthesis reaction (Cook et al., 1992, 1994). Such
reagents have been used to study facets of polyubiquitination
such as the inherent structure of different ubiquitin polymer
types, ubiquitin chain recognition by a variety of ubiquitin-
binding proteins, and the activity and specificity of deubiquitinat-
ing (DUB) proteases that disassemble and regulate polyubiquitin
signals (Bosanac et al., 2010; Dynek et al., 2010; Eddins et al.,
2007; Komander et al., 2009; Lo et al., 2009; Rahighi et al.,
2009; Varadan et al., 2002b). Efforts to further understand the
detailed molecular mechanisms of these and other aspects of
polyubiquitin signaling would benefit greatly from the availability
of methods to readily generate wild-type and mutant polyubiqui-
tin reagents that are of high purity and in greater quantities than
are typically used on a biochemical scale.
Here, we describe optimized methodologies for preparing
high-quality linear, K11-, K48-, and K63-linked polyubiquitin
chains in sufficient quantities to enable structural and biophys-
ical studies, which can be readily implemented in most
biophysics/structure-based laboratories (Bosanac et al., 2010;
Matsumoto et al., 2010). Moreover, this custom synthesis of
ubiquitin polymers allows for the incorporation of specific ubiq-
uitin mutations that can be used to probe intra- and intermolec-
ular interactions and which we utilize here to create site-specific,
fluorescently labeled, polyubiquitin chain reagents.
RESULTS
Preparation of Recombinant Ubiquitin
and Ubiquitination Enzymes
Bacterial expression of recombinant human ubiquitin (Ub;
M1-G76) with an N-terminal, thrombin-cleavable His6-tag typi-
cally yields 80–100 mg of Ub per liter of culture after purification
by immobilized metal affinity chromatography (IMAC) and size
exclusion chromatography. Similar amounts of linear dimeric
(di-UbLinear; M1-G152), trimeric (tri-UbLinear; M1-G228), and
tetrameric (tetra-UbLinear; M1-G304) ubiquitin chains are
produced using this same expression and purification scheme
(Figure 1A and Experimental Procedures). While Ub remains
stable at 4C, the linear ubiquitin chains are flash frozen in liquid
nitrogen and stored at 80C to avoid the gradual breakdown
into individual Ub monomers that is otherwise observed (data
not shown) and likely caused by trace protease contaminants.
For the synthesis of isopeptide-linked ubiquitin chains, we
prepare E1 and E2 enzymes using the bacterial expression
constructs detailed in Figure 1A. Specifically, we utilize human
E1 activating enzyme (UBE1; M1-R1058) for all syntheses and
the E2 enzyme Cdc34 (M1-S236) and the E2 heterodimer,
composed of Uev1a (M1-N170) and UbcH13 (M1-I152)
proteins, for generating K48- and K63-linked chains, respec-
tively. We employ both a full-length and C-terminally truncated
version of the E2 conjugating enzyme Ube2S (M1-L225;
Ube2SDC, M1-G156) for synthesis of K11-linked ubiquitin1054 Structure 19, 1053–1063, August 10, 2011 ª2011 Elsevier Ltd Achains. All of the ubiquitination enzymes are affinity-purified ac-
cording to their specific N-terminal affinity tag (see Figure 1A
and Experimental Procedures) and quantified by A280 measure-
ments under native conditions using calculated molar absorp-
tivity values (ProtParam, SwissProt). Aliquots are then flash
frozen in liquid nitrogen and stored at 80C. Multiple freeze-
thaw cycles are avoided for maximal activity. Working stocks
of Ub that are to be used for chain synthesis reactions are
also quantified by native A280 measurements. However, as there
can be significant error in these values given the small molar
extinction coefficient of Ub (ε = 1490 M-1 cm-1), we determine
the concentration of final Ub and ubiquitin chain stocks that
are to be used in formal experiments by CB X Protein Assay
(G-Biosciences).
Ubiquitin Chain Synthesis and Purification
Prior to preparative chain synthesis, we first assess the activity of
our various ubiquitination enzyme stocks in order to better opti-
mize ubiquitin chain production. To evaluate E1 activation of Ub,
wemonitor ubiquitin-loading of UBE1 in the presence of ATP and
Mg2+. Under these conditions, active UBE1 requires two equiv-
alents of Ub to form a single covalent, thioester linkage to the
C terminus of one of the Ub molecules, which can be detected
as a band shift on a nonreducing SDS-PAGE gel. Instead of using
traditional radiolabeled Ub stocks, we utilize fluorescein-labeled
Ub (Invitrogen) to observe the shift in Ub mobility over a range of
UBE1 concentrations (Figure 1B). We can also monitor these
same E1 activation reactions using fluorescence polarization
(FP), which is sensitive to the noncovalent binding of the second
Ub molecule, in the form of an adenylated intermediate, in addi-
tion to the formation of the covalent Ub attachment (Figure 1C).
Accordingly, these measurements reveal 1:1 and 2:1 stoichiom-
etries for Ub:UBE1 by band shift and FP assays, respectively
(Figures 1B and 1C). Together, these experiments verify that
both active sites on UBE1 are competent to activate Ub and
that approximately 100%of the prepared stock is functional after
one freeze-thaw cycle.
Next, we evaluate the ability of the various E2 conjugating
enzyme stocks to catalyze ubiquitin chain formation in small-
scale test reactions. Here, we add increasing amounts of an
E2 enzyme to UBE1 activation reactions where a fraction of the
Ub is fluorescein labeled. After overnight incubation, the reac-
tions can be run out on a reducing SDS-PAGE gel and the fluo-
rescently labeled Ub and polyubiquitin species can be imaged
and quantified to determine E2 enzyme concentrations that
give maximum chain production (see Figure S1 available online).
Alternatively, a less explicit evaluation of these reactions by FP
measurements (Figure 1D) provides comparable results with
minimal time investment. Except for the inclusion of fluores-
cein-labeled Ub, these test conditions mirror those used for
wild-type preparative chain synthesis (i.e., all reaction compo-
nents are at preparative-scale concentrations); however, the
reaction volumes are kept much smaller for these analytical
samples. In this way, we aim to have the results of the test reac-
tions best translate to large-scale syntheses.
Once the UBE1 stock is validated and optimal E2 concentra-
tions are determined, we proceed to assembling the preparative
Ub chain reactions. We typically react 50 mg of Ub with UBE1
and the appropriate E2 enzyme overnight in E1 activation buffer.ll rights reserved
protein boundaries expression vector affinity tag MW (-tag) description
Ub M1-G76a pET-15b His6-thrombin site 8.8 kDa "WT" Ub monomer
di-UbLinear M1-G152a pET-15b His6-thrombin site 17.6 kDa Ub dimer (linear)
tri-UbLinear M1-G228a pET-15b His6-thrombin site 26.4 kDa Ub trimer (linear)
tetra-UbLinear M1-G304a pET-15b His6-thrombin site 35.2 kDa Ub tetramer (linear)
Ub-M1C C1-G76a pET-15b His6-thrombin site 8.8 kDa labeling-competent Ub mutant
UBE1 M1-R1058 pGEX6P-1 GST-PreScission site 118 kDa E1 activating enzyme
Cdc34 M1-S236 pGEX6P-1 GST-PreScission site 27 kDa E2 conjugating enzyme(K48)
Uev1a M1-N170 EitNTHb His6-TEV site 20 kDa E2 conjugating enzyme (K63)
UbcH13 M1-I152 EitNTHb His6-TEV site 17 kDa E2 conjugating enzyme (K63)
Ube2S M1-L225 pST239 Unizyme 26 kDa (+tag) E2 conjugating enzyme (K11)
Ube2SΔC M1-G156 pST239 Unizyme 20 kDa (+ tag) E2 conjugating enzyme (K11)c
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Figure 1. Validating Enzyme Stocks and Optimizing Reaction Conditions
(A) List of construct boundaries, expression vectors, affinity tags, and molecular weights for the recombinant proteins described in this work.
(B) UBE1-Ub complex formation visualized by fluorescent imaging of samples separated by a nonreducing SDS-PAGE gel (left panel). Quantification of band
intensities (right panel) illustrates how increasing amounts of UBE1 band shifts fluorescein-labeled Ub to form a 1:1 covalent complex.
(C) Analysis of similar samples by FP reveals a 2:1 complex due to a second, noncovalent Ub-binding event.
(D) Addition of E2 conjugating enzymes to Ube1-Ub samples enables ubiquitin chain synthesis, leading to increased FP values as labeled Ub is incorporated into
higher molecular weight polymers. Titration of various E2 stocks helps determine optimal E2 enzyme concentrations for preparative synthesis reactions.
Supporting information is found in Figure S1. In (C) and (D), FP measurements represent the mean ± the standard deviation of triplicate measurements.
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Preparation of Linkage-Specific Ubiquitin ChainsChain synthesis is confirmed by nonreducing SDS-PAGE (see
Experimental Procedures) as shown in Figure 2A. Successful
reactions achieve R50% conversion of Ub to ubiquitin chains,
with ubiquitin dimer being the most abundant species after
free monomer. While these preparations may seem relatively
inefficient, it is important that the amount of free Ub remains
above 30% of the total ubiquitin in a reaction in order to avoid
potential cyclization of ubiquitin polymers (Yao and Cohen,
2000). After verification of chain synthesis, the reactions are
quenched with the addition of 20 volumes of ammonium acetateStructure 19, 1053–buffer to lower the pH and salt concentration of the samples.
Under these acidic conditions, we can effectively separate Ub
and discrete polyubiquitin chains from one another, as well as
from the enzymatic components of the reaction, using cation
exchange chromatography (Figure 2B). Subsequent purification
of each individual chain species by size exclusion chromatog-
raphy allows for further separation of the distinct polyubiquitin
chain lengths (Figure 2C). As described for Ub and linear poly-
ubiquitin stocks, all chains are then quantified by CB 3 protein
assay and stored at 80C.1063, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1055
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Figure 2. Preparative Ub Chain Synthesis and Purification
(A) K11-, K48-, and K63-linked chain synthesis reactions evaluated by SDS-PAGE (see Experimental Procedures). Ubiquitin polymers are simply abbreviated as
Ub(n) for visual clarity (e.g., di-Ub is Ub2, tri-Ub is Ub3, etc.). Asterisks denote small amounts of E2-Ub conjugates visible in the reaction.
(B and C) (B) Mono-S chromatography of a K63-linked chain synthesis reaction separates different length chain products, as illustrated by SDS-PAGE analysis of
the eluted peaks. Further purification by size exclusion chromatography results in (C) highly pure K63-linked, polyubiquitin stocks of discrete lengths. Similar
results achieved with K11- and K48-linked chains are not shown.
(D) The Ube2SDC truncation mutant shifts reaction products toward more intermediate-length K11-linked chains as compared with the full-length Ube2S
enzyme. Furthermore, the yield of tetrameric and hexameric ubiquitin chains substantially improves when using dimeric starting material in chain synthesis
reactions, as demonstrated with a di-UbK48 stock.
Supporting information is found in Figure S2.
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Preparation of Linkage-Specific Ubiquitin ChainsDepending on the amount of polyubiquitin required for a given
study, additional rounds of synthesis can be carried out using the
unincorporated Ub recovered from the initial preparative reac-
tion, and/or previously unused Ub stocks, until enough poly-
ubiquitin is prepared. When tetrameric or hexameric chains are
the desired product, we find it advantageous to conduct a
second round of synthesis using the appropriate ubiquitin dimer
species as the inputmaterial. Doing so significantly increases the
yield of these longer polyubiquitin species as compared with
reactions that use Ub monomer as the basic building block (Fig-
ure 2D). Because monomeric and dimeric ubiquitin species are
well resolved by the cation exchange protocols we describe, it
is unnecessary to polish these stocks by gel filtration prior to
use in further preparative reactions; however, special care
must be taken to ensure that these acidic stocks do not alter
the basic pH of the chain synthesis reactions.
In the case of K11-linked chains, initial efforts to produce
significant quantities of tetramer (and trimer) species were
hindered by the apparently highly processive nature of the
Ube2S E2 enzyme (Garnett et al., 2009; Williamson et al.,
2009; Wu et al., 2010). Although we were able to synthesize
adequate amounts of K11-linked dimer, much of the remaining
Ub starting material was incorporated into very high molecular
weight ubiquitin polymers and Ube2S-ubiquitin conjugates as1056 Structure 19, 1053–1063, August 10, 2011 ª2011 Elsevier Ltd Aopposed to chains of intermediate size (Bosanac et al., 2010).
The demonstration that a C-terminal truncation of Ube2S could
decrease this observed processivity (Wu et al., 2010) lead us
to create a similar deletion mutant, Ube2SDC (residues M1–
G156), for use in preparative synthesis reactions. As illustrated
in Figure 2D and Figure S2, Ube2SDC-catalyzed polyubiquitina-
tion reactions result in a more substantial accumulation of inter-
mediately sized chains as compared with the full-length enzyme.
We therefore employ the Ube2SDC construct for producing K11
chains of discrete lengths, whereas wild-type Ube2S can be best
utilized for synthesizing high molecular weight K11 chains of
heterogeneous size.
Evaluation of Ubiquitin Chain Stocks
Although SDS-PAGE provides a sufficient means of monitoring
the proper separation of different polyubiquitin chain lengths
within a given synthesis reaction, this technique cannot effec-
tively evaluate the homogeneity of ubiquitin linkages within
a given chain population. Ubiquitin polymers can show differen-
tial mobility by SDS-PAGE depending on linkage type; however,
this is a modest effect that is difficult to resolve for every chain
length and linkage composition. Immunoblotting with linkage-
specific antibodies provides a more accurate means of identi-
fying particular chain types (Figure 3A). Yet, despite their provenll rights reserved
A B
std
s
K1
1
K4
8
K6
3
Lin
ea
r
MW
tetramers
coomassie
anti-K11
anti-K48
anti-K63
37
25
37
25
37
25
37
25
C
Ubiquitin-AQUA analysis of purified chain stocks
% Target Chain
K11
Linear
K48
linkage
type
K63
tetramer
96.2
99.9
99.2
99.6
dimer
95.0
100.0
99.2
99.5
0
20
40
60
80
100
Linear K11 K48 K63
Linear
K6
K11
K33
K48
K63
Ubiquitin-AQUA analysis of dimers
purified stocks
%
 to
ta
l U
b 
ch
ai
ns
Figure 3. Evaluating the Homogeneity of
Polyubiquitin Chain Stocks
(A) The linkages of purified tetramer species
evaluated by western blots probed with linkage-
specific antibodies. Currently, only anti-K11, anti-
K48, and anti-K63 antibodies exist; thus, the linear
ubiquitin tetramer in lane 2 is only visible by Coo-
massie staining.
(B and C) (B) Linkage profiles of purified dimers
and (C) a summary table of linkage specificities for
dimer and tetramer stocks as determined by
ubiquitin-AQUA analysis.
Supporting information is found in Figure S3.
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Preparation of Linkage-Specific Ubiquitin Chainsutility, linkage-specific antibodies currently only exist for K11-,
K48-, and K63-linked chains (Matsumoto et al., 2010; Newton
et al., 2008; Tseng et al., 2010). Thus, the remaining chain types
are silent to this analysis and require comparison with immuno-
blots against monomeric ubiquitin to establish or exclude their
presence. Furthermore, the inherent variability of the immuno-
blotting technique in general (e.g., differences both in overall
signal strength and in the low levels of cross-reactivity with off-
target proteins from one blot to another) makes this approach
a qualitative, rather than a quantitative, analysis of polyubiquitin
chain type.
In order to more thoroughly evaluate the homogeneity of link-
ages in our prepared polyubiquitin chain stocks, we employ
a quantitative mass spectrometry methodology called ubiqui-
tin-AQUA (Kirkpatrick et al., 2006; Phu et al., 2010). In this
approach, we first digest polyubiquitin samples excised from
SDS-PAGE gels with trypsin to cleave the chains into peptides,
creating branched ‘‘–GG’’ signature peptides (ggSP) at sites of
ubiquitin linkage. The entire pool of branched and unbranched
peptides derived from the trypsin digestion is then quantified
by mass spectrometry using known amounts of synthetic, isoto-
pically labeled, internal standard peptides. Comparison to these
standards allows for identification and quantification of each
linkage type in a given sample. The sensitivity of this method-
ology enables quantification of femtomolar peptide quantities
and thus provides a rigorous assessment of polyubiquitin linkage
homogeneity of our prepared stocks.
Results from a typical ubiquitin-AQUA evaluation of dimer
and tetramer chain stocks (including di- and tetra-UbLinear chain
stocks for comparison with the synthesized isopeptide-linked
chains) are summarized in Figures 3B and 3C. For di-UbK11,
di-UbK48, and di-UbK63 the targeted chain-linkage type
constitutes 95.0%, 99.2%, and 99.5% of the total chain stock,Structure 19, 1053–1063, August 10, 2011 ªrespectively, while the directly translated
di-UbLinear material exhibits 100% linear
linkages. Similar evaluations of the
tetramer stocks reveal linkage heteroge-
neities that are comparable to those of
the shorter dimer species (Figure 3C);
however, this constitutes the upper range
of purity observed for K11-linked
tetramer. Specifically, we have noted
a slight propensity for the formation of
mixed K11-K63 tetramers during tetra-UbK11 preparation, as evidenced by occasional band doublets
on SDS-PAGE gels of these stocks. Mass spectrometry data
indicate that while the slower migrating band is uniformly
K11-linked, the faster migrating band has substantial contami-
nating K63 linkages (Figure S3). No significant difference in
K11-linkage fidelity is observed for full-length Ube2S enzyme
versus the Ube2SDC truncation mutant.
In sum, the ubiquitin-AQUA results verify the fidelity of the
selected E2 enzymes used in the chain synthesis reactions,
with less than a 0.8% error in linkage specificity for each addition
of Ub protomer to K48 and K63 polymers, and affirm the high
quality of the prepared chain stocks. While K11-linked chains
show less linkage uniformity than the other chain types, the
purity of these stocks has been of sufficiently high quality to
enable structure determination and biophysical studies (Matsu-
moto et al., 2010). Recent work detailing the molecular mecha-
nism of the Ube2S enzyme reveals that the substrate-assisted
catalysis of K11-linked chain formation is mediated by weak
electrostatic interactions (Wickliffe et al., 2011), suggesting that
pH may play a role in specificity. We tested the effect of pH on
linkage specificity and found that Ube2SDC formed fewer K63-
linked chains at higher pH (Figures S3E and S3F). Finally, due
to the general reproducibility of the ubiquitin-AQUA results
over multiple chain syntheses, we do not routinely perform this
analysis on our prepared chain stocks unless we are attempting
to incorporate previously untested forms of mutant or labeled Ub
into the polyubiquitin chains.
Custom Synthesis and Application of Fluorescently
Labeled Ubiquitin Chains
Given the utility of the purchased, fluorescein-labeled Ub in the
E1 and E2 activity assays used to validate our enzyme stocks,
we developed a methodology for synthesizing a variety of2011 Elsevier Ltd All rights reserved 1057
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Preparation of Linkage-Specific Ubiquitin Chainsfluorescently labeled Ub reagents. In our protocol, we first
express andpurify amutantUbconstruct, inwhich the firstmethi-
onine residue is changed to a cysteine (Ub-M1C), as described
above for wild-type Ub. Ub-M1C is then reacted with a malei-
mide-conjugated dye (e.g., fluorescein or Alexa-660) overnight,
the reaction quenchedwith reducing agent and the protein sepa-
rated from free dye by size exclusion chromatography. As wild-
type Ub contains no native cysteines, Ub-M1C is selectively
labeled at the introduced, N-terminal cysteine residue. Purified,
labeled Ub-M1C is flash frozen and stored at 80C.
Inclusion of fluorescein-labeled (Ub-Fl) or Alexa-660-labeled
(Ub-Alexa) protein in Ub stocks (approximately 1% labeled Ub)
used for in vitro polyubiquitin reactions does not appear to affect
the synthesis of K11-, K48-, or K63-linked polyubiqutin chains as
compared with reactions using only unlabeled Ub (Figure 4A).
Moreover, ubiquitin-AQUA analysis of fluorescently labeled
chains reveals no significant alteration in linkage specificity as
compared with unlabeled polymers (Figure 4B). Although addi-
tional dye types may not be as well tolerated as the fluorescein
or Alexa moeities, potential labeling schemes using this method-
ology are theoretically limited only by the availability of free
maleimide-dye reagents.
One key benefit of fluorescently labeled polyubiquitin chains is
the enhancement in signal detection as compared with unla-
beled reagents. The increased sensitivity provided by these fluo-
rescent chains enables significant reagent savings over the
material required for traditional Coomassie staining of SDS-
PAGE samples (Figure 4C). While western blot analysis still
remains a more sensitive technique, the use of fluorescently
labeled Ub enables faster detection and fewer assay compo-
nents than immunoblotting protocols.
To further demonstrate the utility of these fluorescent ubiquitin
chain reagents, we prepared K48- and K63-linked tetramers
labeled with fluorescein and Alexa-660, respectively. Equimolar
mixtures of the tetra-Ub-FlK48 and tetra-Ub-AlexaK63 chains
were treated with the deubiquitinating enzyme, TRABID, and
the resulting samples evaluated by fluorescent SDS-PAGE (Fig-
ure 4D). As previously reported, TRABID preferentially cleaved
the K63-linked chains (Alexa-660 fluorescence) over the K48-
linked chains (fluorescein fluorescence) (Komander et al.,
2009). Because each ubiquitin chain type is tagged with
a different fluorophore, one can test for linkage specificity within
a single reaction by monitoring the two distinct fluorescent
signals. Furthermore, these fluorescent reagents allow for
more complex and/or abundant reaction components that could
complicate analysis when a universal protein detection method
like Coomassie staining is used. Again, while the dye conjugates
may not be universally tolerated in all reactions of biological
interest, this methodology could prove useful for interrogating
a wide range of ubiquitin interactions. The possibility of applying
these reagents to other fluorescence-based applications such
as FP and FRET further broadens their potential utility.
DISCUSSION
The biological significance of ubiquitin modification of proteins
has made the ability to generate and characterize specific inter-
actions with defined-linkage ubiquitin chains an important area
of study. The gold standard approach in this field for generating1058 Structure 19, 1053–1063, August 10, 2011 ª2011 Elsevier Ltd Adimer, trimer or tetramer ubiquitin has been the methodology
developed by Pickart and co-workers involving capping ubiqui-
tin building blocks through point mutations/insertions to force
select chain connectivity (Pickart and Raasi, 2005). This
approach has been used to study the structure and dynamics of
both isolated polyubiquitin chains (dimers or trimers of K48- and
K63-linkedubiquitin) aswell aschains incomplexwithUb-binding
proteins of interest (Blankenship et al., 2009; Newton et al., 2008;
Reyes-Turcu et al., 2008; Sato et al., 2008, 2009; Varadan et al.,
2004, 2005; Zhang et al., 2009). While this method offers precise
control that allows for the differential labeling of specific ubiquitin
protomers within a longer chain, which is advantageous for NMR
approaches, it is timeconsuming, requires expression of a variety
of ubiquitin mutants, and generally provides low yields. In addi-
tion, the capping process results in chains that differ at various
positions from wild-type polyubiquitin. These differences may
have unintended consequences if they impact interactions of
interest. Moreover, this method is limited to chain types for which
E2 or E2/E3 combinations are available, which to date only
includes K11-, K48-, and K63-linkages.
To address this limitation, J.W. Chin and colleagues (Virdee
et al., 2010) developed a novel approach to generate linkage-
specific ubiquitin dimers that chemically couples engineered
Ub constructs and is thus entirely independent of E1 and E2
enzyme activities. In this method, a thioester version of the
‘‘donor’’ Ub is expressed as a Ub-intein fusion, which is then
modified using conventional amine protection chemistry such
that its lysines are incapable of accepting isopeptide bonds.
The ‘‘acceptor’’ Ub protein is generated with a lysine-Boc at
a specific lysine position using unnatural amino acids and amber
codons and the remaining lysine residues are amine protected in
the same manner as the donor Ub molecule. These two chemi-
cally modified Ub proteins are then linked by isopeptide coupling
to generate the dimer of interest, with a single round of global
amine deprotection resulting in the wild-type dimer. This
approach has been successfully used to generate K29 and K6
ubiquitin dimers; however, the complexity of the approach and
the relatively low yield of the accepting Ub with the lysine-BOC
may limit its utility for making longer chains. Additionally, the
chemical conditions of the final deprotection step require unfold-
ing of the ubiquitin chain product—a process that may be
compromised by the refolding inefficiencies of longer polyubi-
quitin chains and/or site-directed mutations that affect the ability
of ubiquitin to refold properly.
Other recent chemical syntheses of ubiquitin dimers avoid the
denaturation process by utilizing thiol-lysines and native chemi-
cal ligation methods to build Ub proteins with alternative lysine
protection groups that enable milder deprotection schemes;
however, these complex,multistep reactions limit overall product
yield (El Oualid et al., 2010; Yang et al., 2010). Fewer steps are
required for another recent, nondenaturing, chemical synthesis
approach in which a ‘‘click reaction’’ is utilized to link an acceptor
Ub with an alkyne-functionalized lysine to a donor Ub containing
anazide-functionalized,C-terminalmethionine substitution (Eger
et al., 2010). As with the intein approach, this methodology
requires a significant investment in tRNAs and non-natural amino
acids that complicate the synthesis of these ubiquitin polymers
and can limit final product yields. Moreover, while initial tests
demonstrate that the resulting triazole-linked ubiquitin dimersll rights reserved
A37
50
25
10
15
20
150
250
100
75
MW
*
*
Ub
Ub2
Ub3
Ub4
Ub5
std
s
Ub
 on
ly
+ 
Ub
-Fl
+ 
Ub
-Al
ex
a
K11 K48 K63
Ub
 on
ly
+ 
Ub
-Fl
+ 
Ub
-Al
ex
a
Ub
 on
ly
+ 
Ub
-Fl
+ 
Ub
-Al
ex
a
37
50
10
15
20
150
250
100
MW
Ub
Ub2
Ub3
Ub4
Ub5
*
std
s
Ub
 on
ly
+ 
Ub
-Fl
+ 
Ub
-Al
ex
a
K11 K48 K63
Ub
 on
ly
+ 
Ub
-Fl
+ 
Ub
-Al
ex
a
Ub
 on
ly
+ 
Ub
-Fl
+ 
Ub
-Al
ex
a
B
D
Ubiquitin-AQUA analysis of WT and fluorescently-labeled chains
% Target Chain
dimer trimer tetramer
94.7
94.4
94.2
90.5
90.7
89.8
83.3
81.9
82.8
99.0
98.9
99.8
96.0
96.8
95.6
92.8
92.8
92.3
99.7
99.4
99.7
99.8
99.7
99.8
99.5
99.1
99.4
K11 Ub-Fl
K11 WT
K11 Ub-Alexa
synthesis
reaction
K48 Ub-Fl
K48 WT
K48 Ub-Alexa
K63 Ub-Fl
K63 WT
K63 Ub-Alexa
C
1 0.5 0.2
5
0.0
62
5
0.0
31
3
0.0
15
6
0.0
03
9
0.0
02
0
0.0
01
0
0.1
25
0.0
07
8
0.0
00
5
0.0
00
3
0.0
00
1
Ub-Fl
Ub-Fl
Ub-Alexa
Ub-Alexa
coomassie
fluorescence
coomassie
fluorescence
μg
+ TRABID (min)
co
ntr
ol
0 10 30 60std
s
37
50
10
15
20
MW
Ub
Ub2
Ub3
Ub4
37
50
10
15
20
MW
+ TRABID (min)
co
ntr
ol
0 10 30 60std
s
Ub
Ub2
Ub3
Ub4
37
50
10
15
20
MW
+ TRABID (min)
co
ntr
ol
0 10 30 60std
s
Ub
Ub2
Ub3
Ub4
K48 Ub-Fl K63 Ub-Alexa merged
Figure 4. Application of Custom-Labeled, Fluorescent Polyubiquitin Chain Stocks
(A) Chain synthesis reactions are not visibly effected by inclusion of 1%Ub-Fl or Ub-Alexa in the Ub pool, with SDS-PAGE analysis of these reactions revealing no
apparent differences with unlabeled Ub reactions by Coomassie staining. Fluorescent scans of the gel prior to staining reveal the presence of polyubiquitin chains
labeled with fluorescein (green) or Alexa-660 (magenta) dye. MW markers prestained with blue dye are also visible in the Alexa channel. Asterisks denote small
amounts of E2-Ub conjugates visible in the reaction.
(B) Ubiquitin-AQUA analysis of discrete bands from the synthesis reactions shown in (A) reveal no differences in linkage fidelity for labeled and unlabeled reactions
(however, the % target chain values determined for bands from unprocessed synthesis reactions are routinely lower than those of purified stocks as shown in
Figures 3B and 3C, with tetra-UbK11 showing the lower range of purity observed for this stock; see also Figure S1).
(C) Serial dilutions of Ub-Fl and Ub-Alexa stocks run on SDS-PAGE illustrate the increased sensitivity of the fluorescent labels over that of Coomassie staining.
(D) A time course of TRABID activity monitored by fluorescent imaging of a SDS-PAGE gel demonstrates the DUB’s specificity for K63-linked chains (Alexa-660
labeled, magenta) over K48-linked chains (fluorescein labeled, green).
Structure
Preparation of Linkage-Specific Ubiquitin Chainsare competent substrates for E6-AP auto-ubiquitination assays,
the lack of an isopeptide bond restricts the utility of these
reagents (e.g., they may not be suitable for DUB recognitionStructure 19, 1053–and cleavage reactions). Similar functional limitations exist for
nonhydrolyzable ubiquitin-isopeptide isosteres chemically
synthesized through oxime linkages (Shanmugham et al., 2010).1063, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1059
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Preparation of Linkage-Specific Ubiquitin ChainsIn contrast to the assortment of approaches discussed above,
themethodwe describe here generatesmultimilligram quantities
of highly pure, wild-type polyubiquitin chains using simple
protein purification protocols and enzyme-driven syntheses
that can be readily implemented in most protein structure/
biophysics-based laboratories. Although this methodology is
currently limited to select chain types (K11-, K48-, K63-linked
and linear chains), it will likely be readily translatable to the
production of K6-, K27-, K29- and K33-linked chains, as selec-
tive E2/E3 enzymes are identified and characterized for these
other linkage types. To date, this approach has been used to
produce defined pools of ubiquitin dimers, trimer, tetramers,
and hexamers for biophysical and crystallographic studies (Bo-
sanac et al., 2010; Dynek et al., 2010; Matsumoto et al., 2010)
and K.C.D. and S.G.H. (unpublished data) and has proved to
be robust to mutations that allow for fluorescent labeling of ubiq-
uitin (e.g., Ub-M1C) or that affect ubiquitin function (e.g., I44A).
Indeed, it is the ability to make specifically mutated chains that
will enable detailed analyses of both intrachain and intermolec-
ular interactions, which are critical to our understanding of how
distinct polyubiquitin chain signals are interpreted by the cell.
Custom synthesis of fluorescently labeled chains should also
provide powerful tools to investigate questions of ubiquitin
biology, enabling biochemical and biophysical studies that are
intractable with currently available reagents.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Ubiquitin, Linear Ubiquitin
Chains, and Ubiquitination Enzymes
We employed Genescript to synthesize genes encoding di-UbLinear (M1-G152)
and tetra-UbLinear (M1-G304). Because of highly repetitive elements, the
sequences were first codon optimized for efficient cloning and expression,
then synthesized with NcoI and BamHI restriction sites to enable cloning into
a pUC57 vector. We subsequently subcloned the genes into the same pET-
15b bacterial expression plasmid (Invitrogen) as our monomeric Ub construct
(M1-G76). A linear trimeric ubiquitin gene (M1-G228) was amplified from the
tetrameric expression construct and subcloned into the pET-15b vector, as
well. All constructs (Ub, di-UbLinear, tri-UbLinear and tetra-UbLinear) contain
a thrombin-cleavable, N-terminal His6-tag (MGSSHHHHHHSSGLVPR/GSH)
and were expressed and purified as previously described for monomeric Ub
(Bosanac et al., 2010). Briefly, constructs were transformed into BL21 pLysS
cells, which were grown at 37C in TB media buffered with 100 mM MOPS
(pH 7.3) to an OD600 of 1.5–2.0 and the cultures cooled to room temperature
prior to inductionwith 0.5mM IPTG.Cellswere harvested and frozen after over-
night growth at 16C.Cell pastewas resuspendedandhomogenized inUb lysis
buffer (40 mM Tris [pH 8.0], 0.3 M NaCl) supplemented with EDTA-free
Complete protease inhibitor tablets (Roche), the cells lysedby three successive
passages through a M-110Y microfluidizer (Microfluidics, USA) and centri-
fuged to pellet cell debris. The resulting supernatant was passed over Ni-NTA
resin (QIAGEN) andwashedwithUbwash buffer (20mMTris [pH7.2–7.5], 0.3M
NaCl, 0.2 mM TCEP, 5 mM bME, 20 mM imidazole). Target protein was eluted
with Ub wash buffer increased to 250 mM imidazole and dialyzed into Ub dial-
ysis buffer (20 mM Tris [pH 8.0], 150 mM NaCl) in the presence of 1 unit of
thrombin (CalBiochem) per 10 mg protein at 4C overnight in order to remove
the His6-tag. Uncleaved protein was captured on Ni-NTA (QIAGEN) and the
flow through was concentrated for size exclusion chromatography. In batches
of about100mg, ubiquitin monomer or each of the linear chains was injected
on a HiLoad 26/60 Superdex 75 (GE Lifescience) in Ub SEC buffer (20 mM Tris
[pH 7.5], 150 mMNaCl). Purity was monitored using SDS-PAGE and Coomas-
sie staining. Here, it is important to note that the Tris-Glycine SDS gel loading
buffer used did not contain reducing agent, the samples were not heated prior
to gel loading, and the samples were mixed with loading buffer just prior to
running the gel. Preparation of gel samples in this way limits the highmolecular1060 Structure 19, 1053–1063, August 10, 2011 ª2011 Elsevier Ltd Aweight laddering artifacts sometimes observed in SDS-PAGE analyses of
concentrated Ub stocks. Final recombinant ubiquitin pools were then concen-
trated and stored at 4C (Ub) or 80C (linear Ub chains).
UBE1 (M1-R1058) and Cdc34 (M1-S236) are pGEX6P-1 GST-tagged
constructs with PreScission protease sites (Amersham). GST-UBE1 and
GST-Cdc34 expressing bacteria were harvested by centrifugation and cell
pellets resuspended in E1/Cdc34 lysis buffer (50 mM Tris-HCl [pH 7.5],
0.45M NaCl, 0.5% Triton X-100, 5 mM EDTA, 1 mM DTT) supplemented
with protease inhibitor cocktail tablets (Roche). Samples were lysed as
described above and the supernatant fraction was batch loaded onto gluta-
thione Sepharose 4B resin (AmershamBiosciences) for 1 hr at 4C. The loaded
resin was washed with E1/Cdc34 lysis buffer followed by GST cleavage buffer
(50mMTris-HCl [pH 7.5], 0.45MNaCl, 5mMEDTA, 1mMDTT), then decanted
into a conical tube and incubated with 40 ml PreScission Protease (Amersham)
per milliliter of resin. The cleavage reaction was rotated overnight at 4C, and
then the resin was loaded onto a BioRad EconoPac column and the flow
through was collected. The resin was washed with additional GST cleavage
buffer and the pooled flow through and wash fractions were dialyzed overnight
against either E1 dialysis buffer (50 mM HEPES [pH 8.0]) or Cdc34 dialysis
buffer (50 mM HEPES [pH 8.0], 50 mM NaCl, 10% glycerol, 1 mM DTT).
Samples were flash frozen in liquid nitrogen and stored at –80C.
Uev1a (M1-N170) andUbcH13 (M1-I152) areHis-tagged constructswith TEV
protease sites. These proteins were expressed in BL21(DE3) cells and lysed in
K63-E2 lysis buffer (20 mM Tris 80, 10% glycerol, 300 mM NaCl, 2 mM b-mer-
captoethanol, 0.2mMTCEP,0.1%TritonX-100) andprotease inhibitorsaccord-
ing to procedures described above. Both constructs were purified by passage
over a Ni-NTA (QIAGEN) affinity column using K63-E2 buffer A (20 mM Tris
8.0, 150mMNaCl,0.2mMTCEP,2mMBME,10mMimidazole) andelutedusing
K63-E2 buffer A plus 250 mM imidazole. Following overnight incubation with
TEV protease to remove the His tag, the proteins were passaged over a second
Ni-NTA (QIAGEN) affinity columnusing the samebuffersasabove to removeany
uncleaved material. Final purification was achieved by size exclusion chroma-
tography using a Superdex 75 column (GE Lifescience) in 20 mM HEPES 7.5,
150 mM NaCl, and 0.5 mM TCEP. Proteins were quantified by A280, mixed at
a 1:1 molar ratio and flash frozen in liquid nitrogen for 80C storage.
Ube2S (M1-L225) and Ube2SDC (M1-G156) were cloned into the in-house
pST239 vector with an N-terminal unizyme tag under the control of an alkaline
phosphotase promoter and expressed in 58F3 cells [derived from W3110 with
genotype DfhuA(DtonA) Dlon galE rpoHts(htpRts) DclpP lacIq DompTD (nmpc-
fepE) DslyD] (Szeto et al., 2001). Small-volume cultures were grown overnight
at 30C and then diluted 100-fold into a phosphate-limiting medium to induce
thealkalinephosphatasepromoter. After 24hr at 30Cwith shaking, the cultures
were centrifuged, and cell pellets harvested. Cells were resuspended in Ube2S
lysis buffer 2 (20mM phosphate [pH 8.0], 150mMNaCl, 0.5 mM TCEP) supple-
mented with protease inhibitors. Following homogenation and lysis protocols
detailed above, the samples were centrifuged and the soluble fraction was
loaded onto a Ni-NTA (QIAGEN) column equilibrated in Ube2S buffer A
(25 mM Tris-HCl [pH 80], 1 M NaCl, 20 mM imidazole). After washes with addi-
tional Ube2S buffer A, the Ube2S constructs were eluted with Ube2S elution
buffer (25mMTris-HCl [pH 8.0], 0.5MNaCl, 250mM imidazole). These fractions
werepooled, concentrated, and furtherpurifiedusingsizeexclusionchromatog-
raphy with a Superdex 75 column equilibrated (GE Lifescience) in Ube2S SEC
buffer (20 mM HEPES [pH 7.5], 0.15 M NaCl, 0.5 mM TCEP). Fractions corre-
sponding to monomeric Ube2S or Ube2SDCwere pooled and stored at –80C.
Full-length TRABID (E3-E708) was expressed with an N-terminal His6-tag in
T.ni insect cells. Cell paste was resuspended in TRABID buffer A (50 mM Tris
8.0,300mMNaCl, 10mMb-mercaptoethanol, 10mMimidazole) supplemented
with protease inhibitors and lysed as described above. Clarified lysate was
affinity purified using Nickel Sepharose Fast Flow resin (QIAGEN) and eluted
using TRABID buffer A with 250 mM imidazole. Eluted sample was cleaved
with TEV protease overnight at 4C, passed over a second nickel column and
further purified over a Superdex 200 column (GE Amersham, USA) equilibrated
in20mMTris-HCl (pH8.0), 0.5MNaCl, and2mMb-mercaptoethanol. Fractions
containing TRABID were pooled, concentrated, and stored at 4C.
E1 Activation Assays and E2 Titrations
UBE1 activation was measured using a modified method derived from Pickart
et al. and Haas et al., in which we replaced radioactive 125I-G76A Ub withll rights reserved
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Preparation of Linkage-Specific Ubiquitin Chainsfluorescently labeled Ub (Fl-ubiquitin) purchased from Invitrogen (Haas et al.,
1982; Pickart et al., 1994). UBE1 (9–500 nM) was reacted with 150 nM Fl-ubiq-
uitin, 2 mM ATP, 4 mMMgCl2, and 50 mM Tris-HCl (pH 8.0) for 30 min at room
temperature. Aliquots were transferred to a 386-well plate and read on a Victor
3 (Perkin Elmer) equipped with 485 ± 30 nm excitation and 535 ± 40 nm emis-
sion filters to measure fluorescence polarization of the samples (Figure 1C). To
assess the reactions via gel-shift (Figure 1B), an equal volume of 50% glycerol
was added to the remaining samples, which were then separated by SDS-
PAGE and fluorescence signal detected with a blue (488 nm) laser and
a 526 ± 20 nm emission filter using a Typhoon imager (GE Amersham). Band
intensities were quantified using ImageQuant (GE Amersham). To evaluate
E2 activity, we monitored the production of fluorescein-labeled polyubiqitin
chains for a range of E2 concentrations. Small-scale test reactions (15 ml)
were set up using similar conditions as described for the preparative synthesis
reactions in the proceeding section, except that50 nMFl-Ub (Invitrogen) was
preincubated with the E1 enzyme for 15 min at room temperature prior to the
addition of unlabeled Ub and E2 enzyme. Reactions were incubated overnight
at 37C and the resultant fluorescent species assessed by SDS-PAGE and FP
measurements as described above. Data were plotted to assess optimal E2
concentrations for preparative synthesis reactions. These and all other plots
presented here were generated using Kaleidagraph version 3.6 (Synergy
Software).
Polyubiquitin Chain Synthesis and Purification
To generate preparative quantities of polyubiquitin chains, a reaction mixture
containing50mg of Ub at a final concentration of 1–1.5mM,with 0.5 mMUBE
and E1 activation buffer (50 mM Tris [pH 8.0], 10 mM ATP, 4–10 mM MgCl2)
and 0.6 mM DTT was incubated with either 30–50 mM Ube2SDC, 5–10 mM
Cdc34 or 2.5–5 mMUev1a/UbcH13 for K11, K48, or K63 linkages, respectively
(Komander et al., 2008; Pickart and Raasi, 2005; Wu et al., 2010). Exact E2
enzyme concentrations used depended upon the specific activity measured
for particular E2 preparations (see Figure 1D). One should note that ATP regen-
erating systems (e.g., 20 mM creatine phosphate, 1.2 U/ml inorganic pyro-
phosphate, 1.2 U/ml creatine phosphokinase) are also compatible with these
general synthesis conditions and may be used to drive chain production.
Reactions were incubated overnight at 37C, assessed by SDS-PAGE and
quenched by 20-fold dilution into buffer A1 (50 mM ammonium acetate,
100mMNaCl [pH 4.5]). Polyubiquitin chains of defined lengths were separated
on a MonoS 10/100 GL column (GE LifeScience) with a 45 column volume
gradient of buffers A1 and B (50 mM ammonium acetate [pH 4.5], 0.6 M
NaCl). A portion of the dimeric ubiquitin was pooled from the MonoS column
elution, concentrated, and exchanged into Ub SEC buffer, through dilution
and reconcentration, to lower the salt concentration to 150 mM and increase
the pH to 7.5. This dimer pool was then used to create sufficient tetramer
chains utilizing the reaction conditions stated above, where dimer replaces
monomeric ubiquitin as the starting material. The separation of these higher
order chains was then accomplished using a 45 column volume gradient of
buffers A2 (50 mM ammonium acetate [pH 4.5], 0.3M NaCl) and B. Each chain
length was pooled separately and concentrated to less than 1 ml for injection
onto a HiLoad 16/60 Superdex 75 (GE LifeScience) for final purification to
homogeneity. The resulting chain stocks were concentrated, quantified, and
stored at 80C.
Preparing Fluorescently Tagged Ubiquitin and Polyubiquitin Chains
To produce labeled ubiquitin stocks, 2 mg of Ub-M1C was first reduced with
ten molar excess of Tris(2-carboxyethyl)phosphine (TCEP) and then reacted
with a 10-fold molar excess of flourescein-maleimide (Invitrogen) or Alexa-
660-maleimide (Invitrogen) overnight at 4C. The reactions were quenched
with 2.9 mM b-mercaptoethanol, dialyzed into Ub SEC buffer and loaded
onto a Sephacryl 100 column (GE Amersham) to remove unbound dye. Chain
synthesis reactions containing 1% labeled Ub were carried out as described
above with the following exceptions: 3 mMUBE1 was preincubated with either
15 mM Ub-Fl or Ub-Alexa in E1 activation buffer for 15 min at 37C prior to the
addition of unlabeled Ub and E2 enzyme(s) for overnight incubation at the
same temperature. Reaction products were separated by SDS-PAGE and
scanned using a Typhoon imager prior to Coomassie staining. Chains contain-
ing Ub-Fl were detected using the settings detailed above whereas chains
labeled with Ub-Alexa were imaged using a red (630 nm) laser and aStructure 19, 1053–670 ± 30 nm emission filter. Purified tetra-Ub-FlK48 and tetra-Ub-AlexaK63
stocks were prepared in a similar fashion; however, the order of the chain
synthesis and labeling steps was reversed. Specifically, we first synthesized
and purified tetrameric chains as described above, using a monomeric Ub
starting pool that contained 10% Ub-M1C. This Ub pool was preincubated
in chain synthesis reaction buffer for 5 min prior to addition of the remaining
reaction components to reduce potential disulfide bonds formed between
Ub-M1C molecules in the concentrated stock. Purified tetramers were then
reacted with dye (tetra-UBK48 with fluorescein-maleimide and tetra-UbK63
with Alexa-660-maleimide) and purified as described above for monomeric
Ub-M1C protein.Quantitative Mass Spectrometry
The composition of Ub chains was determined by either multiple-reaction
monitoring on a QTrap4000 or from high-resolution full MS scans on an
LTQ-Orbitrap XL mass spectrometer, as recently described (Kirkpatrick
et al., 2006; Phu et al., 2010). Briefly, purified Ub chain stocks or chain
synthesis reactions were separated by SDS-PAGE and polyubiquitin bands
subjected to in-gel trypsin digestion with 20 ng/ml trypsin solution (50 mM
ammonium bicarbonate/5% acetonitrile). Isotope-labeled synthetic peptides
of Ub and the branched Ub signature peptides (ggSP) were added to gel
pieces prior to extracting the digested peptides. Extracted peptides were
dried completely, resuspended and separated by reverse phase HPLC using
standard water/acetonitrile/formic acid based gradients. Since AQUA peptide
stock concentrations can vary systematically from their measured concentra-
tions following preparation of diluted mixtures, separate di-Ub bands of
multiple linkages were analyzed in parallel with each experiment as controls.
The total amount of Ub in a control di-Ub band was initially determined as
the average of independent measurements made for unbranched peptides
and ggSP from the K11, K33, K48, and K63 loci. Correction factors were deter-
mined for ggSPs based on the defined 1:2 stoichiometry of linkage to total Ub
for a given dimer, and corrected ggSP values reintroduced to generate revised
total Ub amounts. The process was repeated through two iterations. The
abundance of a given linkage is reported as percent total Ub chains, represent-
ing the calculated abundance of a given ggSP relative to the sum of ggSP from
all chains.DUB Assay
TRABID was diluted to 10 mM in 25 mM Tris (pH 7.5), 150 mM NaCl, and
10 mMDTT and preincubated for 20 min at room temperature. A final concen-
tration of 1 mM TRABID was incubated with a mixture of 500 nM tetra-UbK48
and 500 nM tetra-UbK63 labeled with approximately 10% fluorescein, and
10% Alexa-660, respectively, in assay buffer (50 mM Tris [pH 7.5], 50 mM
NaCl, 2 mM DTT) at room temperature. Aliquots were removed at specific
time points to an equivalent volume of 2 3 SDS sample buffer and heated
at 94C for 5 min in order to stop the reaction. Samples (4 ml) were separated
by SDS-PAGE and imaged by Typhoon scanner prior to Coomassie staining
as described above.SUPPLEMENTAL INFORMATION
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